One day Open Access Workshop was organized on November 18, 2009 at the University of Hyderabad at the initiative of the Indira Gandhi Memorial Library of the University. Professor Seyed E Hasnain, Vice-Chancellor, inaugurated the workshop and delivered his keynote speech. He stressed for the need to make the scientific literature open and free of cost. The university is planning to usher into green open access very soon.
Wednesday, November 25, 2009
Designer probiotics: the future or too much to stomach?
Although the benefits of probiotics have been postulated for more than 100 years, there has been an increasing interest in the effects of probiotics on ill health and general well being over recent years.
Studies have shown positive outcomes of probiotics in the treatment and prevention of gastrointestinal infections and disease. But are generic probiotics enough? In the review "Probiotics and gastrointestinal disease: successes, problems and future prospects" published in Gut Pathogens, Eamonn Culligan et al. review the treatment of various GI disorders with specific probiotic strains. They also discuss whether the future lies with designer probiotics, which are engineered to specifically target a particular toxin or pathogen, but raise concerns of a negative public reaction to the development of this possible course of treatment.
Will designer probiotics be the future treatment of GI disorders? Or will public resistance for genetically modified organisms hinder its progress? (Source: Biomed Central Blog)
Studies have shown positive outcomes of probiotics in the treatment and prevention of gastrointestinal infections and disease. But are generic probiotics enough? In the review "Probiotics and gastrointestinal disease: successes, problems and future prospects" published in Gut Pathogens, Eamonn Culligan et al. review the treatment of various GI disorders with specific probiotic strains. They also discuss whether the future lies with designer probiotics, which are engineered to specifically target a particular toxin or pathogen, but raise concerns of a negative public reaction to the development of this possible course of treatment.
Will designer probiotics be the future treatment of GI disorders? Or will public resistance for genetically modified organisms hinder its progress? (Source: Biomed Central Blog)
Subscribe to:
Posts (Atom)